Skip to main content

Table 2 Demographic characteristics of patients admitted for percutaneous coronary intervention in selected studies

From: Systematic review and meta-analysis of the prognostic impact of cancer among patients with acute coronary syndrome and/or percutaneous coronary intervention

 Hess et al.Nakatsuma et al.Landes et al. (*)
Characteristics, n (%)Cancer
n = 496
No cancer
n = 14,512
Cancer
n = 1109
No cancer
n = 11,071
Cancer
n = 969
No cancer
n = 969
Age (years)68 (61.8)62 (53.7)73.2 ± 8.567.8 ± 11.176.6 ± 10.176.9 ± 9.2
Men354 (71.4)9586 (66.1)825 (74.4)7976 (72)700 (72.2)700 (72.2)
Systemic hypertension334 (67.3)9478 (65.3)904 (81.5)9100 (82.2)843 (87)843 (87)
Diabetes mellitus129 (26)4013 (27.7)440 (39.7)4154 (37.5)318 (45.7)318 (45.7)
Hyperlipidemian/an/an/an/a  
Active smoker238 (48)7712 (53.1)230 (20.7)3648 (33)230 (23.7)204 (21.1)
History of
 Myocardial infarction246 (49.6)7414 (51.1)119 (10.7)1141 (10.3)n/an/a
 PCIn/an/an/an/an/an/a
 CABGn/an/an/an/a185 (19.1)196 (20.2)
 Stroke66 (13.3)1196 (8.2)142 (12.8)1149 (10.4)87 (9)63 (6.5)
 Anemian/an/a228 (20.6)1165 (10.5)n/an/a
Presentation
 ACS329 (66.6)10,481 (72.4)317 (28.6)2992 (27)592 (61.1)527 (54.4)
Number of diseased vessels
 1 vessel255 (55.8)8839 (65.4)n/an/a163 (16.9)175 (18.1)
 2 vessels131 (28.7)3095 (22.9)n/an/a320 (33)310 (32)
 3 vessels71 (15.5)1574 (11.7)n/an/a485 (50.1)369 (40.9)
Procedure
 Drug-eluting stent164 (54.5)4209 (62.1)570 (51.4)6218 (56.2)392 (40.5)465 (48)
 Bare metal stentn/an/an/an/a529 (54.6)464 (47.9)
Treatment at discharge
 Beta-blockers447 (90.1)13,077 (90.1)294 (27)3410 (31)n/an/a
 ACE/ARBs418 (84.3)10,992 (75.7)571 (51)6573 (59)n/an/a
 Statinsn/an/a487 (44)5816 (53)n/an/a
 Aspirin489 (98.6)14,355 (98.9)1092 (98)10,936 (99)n/an/a
 P2Y12 Inhibitors437 (88.1)11,023 (76)136 (13)1018 (9.3)n/an/a
  1. ACE Angiotensin-Converting Enzyme; ACS Acute Coronary Syndrome; ARBs Angiotensin Receptor Blockers; CABG Coronary Artery Bypass Grafting; PCI Percutaneous Coronary Intervention
  2. (*) data of the matched patients